Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05913908 · ClinicalTrials.gov registry record · NA

EFS of the DUO System for Tricuspid Regurgitation

A NA study of Tricuspid Regurgitation and Heart Valve Diseases, sponsored by CroiValve Limited.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
16
Study locations

NCT05913908 is a NA study of Tricuspid Regurgitation and Heart Valve Diseases that is actively recruiting participants, run by CroiValve Limited. The registered enrollment target is 15 participants, below the 535-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (97% lower). The trial reports 16 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05913908, a NA study of Tricuspid Regurgitation and Heart Valve Diseases, is actively recruiting participants, sponsored by CroiValve Limited.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
16
Study locations

Study Summary

The study is an early feasibility study to measure individual patient clinical outcomes and effectiveness, evaluate the safety and function of the DUO Transcatheter Tricuspid Coaptation Valve System (DUO System).

Conditions Studied

Tricuspid Regurgitation Heart Valve Diseases Tricuspid Valve Disease Tricuspid Valve Insufficiency

Interventions

  • DEVICE DUO Transcatheter Tricuspid Coaptation Valve System

Study Locations (16)

New York

  • Columbia University Medical Center/NYPH - New York
  • Montefiore Medical Center - The Bronx

Arizona

  • Dignity Health St. Joseph's Hospital & Medical Center - Phoenix

California

  • Los Robles Hospital & Medical Center - Thousand Oaks

Georgia

  • Piedmont Heart Institute - Atlanta

Illinois

  • Northwestern University - Chicago

Kansas

  • Ascension Via Christi Research - Wichita

Minnesota

  • Allina Health Minneapolis Heart Institute Foundation - Minneapolis

Ohio

  • OhioHealth Research Institute - Columbus

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2024-08-13
Est. Completion 2029-10
Phase NA

Sponsor

CroiValve Limited

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05913908

The ClinicalTrials.gov registry entry for NCT05913908 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 535-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (97% lower). The listed sponsor is CroiValve Limited, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Tricuspid Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which DUO Transcatheter Tricuspid Coaptation Valve System is the first listed.

NCT05913908 reports 16 study locations spanning 15 distinct geographic areas - top geographies include New York, Arizona, California.

Frequently Asked Questions

What is clinical trial NCT05913908 about?

NCT05913908 is a clinical study titled "EFS of the DUO System for Tricuspid Regurgitation". The study is an early feasibility study to measure individual patient clinical outcomes and effectiveness, evaluate the safety and function of the DUO Transcatheter Tricuspid Coaptation Valve System (DUO System).

What is the current status of trial NCT05913908?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-08-13. Estimated completion is 2029-10.

What conditions does trial NCT05913908 study?

This clinical trial studies the following conditions: Tricuspid Regurgitation, Heart Valve Diseases, Tricuspid Valve Disease, Tricuspid Valve Insufficiency.

What interventions are being tested in trial NCT05913908?

The interventions under investigation include: DUO Transcatheter Tricuspid Coaptation Valve System (DEVICE).

Who is sponsoring clinical trial NCT05913908?

This trial is sponsored by CroiValve Limited, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05913908 being conducted?

This trial has 16 study locations across Arizona, California, Georgia, Illinois, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tricuspid Regurgitation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Tricuspid Regurgitation

All registered trials for this condition

Heart Valve Diseases

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.